Myo-inositol in the form of phosphate derivatives (inositol phosphoglycans) exerts an insulin-mimetic activity, acting downstream of insulin receptors to reduce hyperglycemia and promote muscular gluconeogenesis (Huang et al., 1993; Ortmeyer et al., 1993). The gene discussed is INSR; the disease is Hyperglycemia.